Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 3 results out of 3
Data Insights
Insulin efsitora alfa by Eli Lilly and Co for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Insulin efsitora alfa is under clinical development by Eli Lilly and Co and currently in Phase III for Type 1...
Data Insights
Insulin efsitora alfa by Eli Lilly and Co for Type 2 Diabetes: Likelihood of Approval
Insulin efsitora alfa is under clinical development by Eli Lilly and Co and currently in Phase III for Type 2...
Data Insights
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's Insulin efsitora alfa?
Insulin efsitora alfa is a fusion protein commercialized by Eli Lilly and Co, with a leading Phase III program in...